Werewolf Therapeutics Inc (HOWL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 1,885 | 19,943 | 16,401 | 0 | 0 |
| Gross Profit | 1,885 | 19,943 | 16,401 | N/A | N/A |
| Operating Expenses | 75,479 | 60,446 | 72,457 | 50,087 | 22,404 |
| Operating Income | -73,594 | -40,503 | -56,056 | -50,087 | -22,404 |
| Interest Expense | 4,656 | 3,139 | 0 | 0 | 0 |
| Other Income | 7,735 | 6,274 | 2,246 | 104 | 7,364 |
| Pre-tax Income | -70,515 | -37,368 | -53,810 | -49,983 | -15,040 |
| Net Income Continuous | -70,515 | -37,368 | -53,810 | -49,983 | -15,040 |
| Net Income | $-70,515 | $-37,368 | $-53,810 | $-49,983 | $-15,040 |
| EPS Basic Total Ops | -1.63 | -1.05 | -1.86 | -10.94 | -28.08 |
| EPS Basic Continuous Ops | -1.63 | -1.05 | -1.86 | -2.71 | -14.97 |
| EPS Diluted Total Ops | -1.63 | -1.05 | -1.86 | -10.94 | -28.08 |
| EPS Diluted Continuous Ops | -1.61 | -1.05 | -1.86 | -2.71 | -14.97 |
| EPS Diluted Before Non-Recurring Items | -1.63 | -1.05 | -1.86 | -10.94 | N/A |
| EBITDA(a) | $-71,780 | $-38,679 | $-54,749 | $-49,871 | $-22,254 |